CELH has 33.60 as a recent swing high; 20-day average is 32.10. I’d fade a clean break above with tight stops.
Any update on CELH’s roadmap beyond this price tag?
Every time they say 'hold 33.60,' the tape screams otherwise. If it’s truly a long-term plan, why the noise? Feels like a marketing line to prop up sentiment while liquidity thins around that level.
Is this a good entry point, or wait for relief?
Is this just VOO’s weakness dragging SPMO, or is SPMO facing its own headwinds? Anyone tracking earnings or guidance?
As a long-term holder, I care more about SPMO’s dividend growth and expense ratio than today’s noise. If it’s just a market-wide jolt, I’ll keep the position and let compounding run.
Feels heavy; everyone’s leaning bearish on ENPH.
Anyone else notice the 12-month chart of ENPH showing multiple down days in a row, 50-day below 200-day, and a 20% drawdown since last year? If this is the trend, what’s the realistic floor before a bounce?
Seen this movie with biotech and small caps before—sharp selloffs, then choppy recovery. I’m cautious, not panicked, and waiting for a real catalyst.
Feels like the market’s punishing patience right now. I’m cautiously optimistic but tired of waiting for what might not come.
Why do we keep chasing 2027? Guidance is vague, comps are noisy, and analysts already priced in a long wait. Feels like FOMO, not strategy.
Holding TTWO—waiting till 2027 feels risky.
Biotech pops, but pharma catalysts feel thin today.
Is everyone just praying to the tape again, or is there real catalysts to justify this break?
Feels like a classic breakout setup, but I’m not convinced. If volume fades, this could be a fakeout. I’d rather see a close above 10.80 with rising volume before chasing.
